July 9, 2024 | Customer story, Impetus Digital, Innovative Clinical Trial, Phase II, client success story, clinical trial, clinical trial investigators, insight gathering, online investigators, phase 2, virtual community board
Discover how Impetus Digital transformed a multicenter Phase III clinical trial with their innovative virtual solutions.

Our client leveraged Impetus Digital’s virtual solutions to hold a series of investigator meetings and streamline their multicenter Phase III clinical trial. Using a mix of synchronous and asynchronous virtual touchpoints, as well as an online Investigator Community Board, Impetus facilitated ongoing collaboration, best practice sharing, and problem-solving, along with comprehensive training on the trial protocol and regulatory considerations.
This strategic approach not only enhanced the efficiency of the clinical trial by improving communication between investigators and trial sites but also led to significant cost-savings and faster patient recruitment. Access the customer story to get the details!
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Farah Husein, Director, Evidence Generation, Canadian Centre of Excellence, at Takeda, discusses all things evidence generation, including the impact of the COVID-19 pandemic on HEOR, RWE, epidemiology, and PRO studies and…
Press ReleaseContact: Jess Masciangelo, Business Development Directorjmasciangelo@impetusdigital.commeetwithimpetus.comINSITE EVENTâ„¢ NAMED ONE OF THE MOST INNOVATIVE SERVICES OF 2020Toronto, ON, December 10, 2020 — Impetus Digital’s new virtual event platform InSite Eventâ„¢…
Nance Dicciani &Â Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices….
Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,…
Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating…
Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support…
Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and…
Kimberly Tableman, CEO at Medicine X, discusses a myriad of topics related to digital transformation and patient centricity, including how digital health technologies can be used to reimagine the patient…
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events…
Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health…
